AWM
CNMD icon

Altavista Wealth Management’s CONMED CNMD Stock Holding History

Altavista Wealth Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,105
Closed -$215K – 147
2017
Q3 		$215K Buy
+4,105
New +$206K 0.1% 132

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altavista Wealth Management's CNMD Position: Q4 2017 in Review

Altavista Wealth Management sold out of CONMED (CNMD) in Q4 2017, closing a stake of 4,105 shares — an estimated $215K sold.

Altavista Wealth Management first reported a position in CNMD in Q3 2017 and held it in 1 quarter. The position peaked at $215K in Q3 2017. 160 funds tracked by Wall St. Rank hold CNMD as of Q4 2017.

  • Altavista Wealth Management reported no remaining CONMED position as of Q4 2017 after selling out during the quarter.
  • Altavista Wealth Management sold 4,105 CONMED shares in Q4 2017, an estimated $215K.
  • Altavista Wealth Management first reported a position in CONMED in Q3 2017 and held it in 1 quarter.
  • Altavista Wealth Management's CONMED position peaked at $215K in Q3 2017.
  • 160 funds tracked by Wall St. Rank held CONMED as of Q4 2017.

Based on Altavista Wealth Management's 13F filing for Q4 2017, filed 13 Feb 2018.